日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigating the Role of A20 in Respiratory Syncytial Virus Immunopathogenesis in a BALB/c Mouse Model

在BALB/c小鼠模型中研究A20在呼吸道合胞病毒免疫发病机制中的作用

Tahamtan, Alireza; Yasaghi, Mohammad; Samadizadeh, Saeed; Nikoo, Hadi Razavi; Yamchi, Ahad; Salimi, Vahid

Benign mass-like lesion at the cholecystectomy bed: A case report of unusual postcholecystectomy imaging findings

胆囊切除术后床旁良性肿块样病变:一例罕见的胆囊切除术后影像学表现病例报告

Yazdi, Niloofar Ayoobi; Tahamtan, Mohammadreza; Rahmani, Shahriar; Salahshour, Faeze; Alizadeh, Sajjad; Cannella, Roberto

Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial

作者更正:达雷妥尤单抗联合硼替佐米、来那度胺和地塞米松治疗不适合移植或因故推迟移植的新诊断多发性骨髓瘤:随机3期CEPHEUS试验

Usmani, Saad Z; Facon, Thierry; Hungria, Vania; Bahlis, Nizar J; Venner, Christopher P; Braunstein, Marc; Pour, Ludek; Martí, Josep M; Basu, Supratik; Cohen, Yael C; Matsumoto, Morio; Suzuki, Kenshi; Hulin, Cyrille; Grosicki, Sebastian; Legiec, Wojciech; Beksac, Meral; Maiolino, Angelo; Takamatsu, Hiroyuki; Perrot, Aurore; Turgut, Mehmet; Ahmadi, Tahamtan; Liu, Weiping; Wang, Jianping; Chastain, Katherine; Vermeulen, Jessica; Krevvata, Maria; Lopez-Masi, Lorena; Carey, Jodi; Rowe, Melissa; Carson, Robin; Zweegman, Sonja

Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial

达雷妥尤单抗联合硼替佐米、来那度胺和地塞米松治疗不适合移植或因故推迟移植的新诊断多发性骨髓瘤:一项随机3期CEPHEUS试验

Usmani, Saad Z; Facon, Thierry; Hungria, Vania; Bahlis, Nizar J; Venner, Christopher P; Braunstein, Marc; Pour, Ludek; Martí, Josep M; Basu, Supratik; Cohen, Yael C; Matsumoto, Morio; Suzuki, Kenshi; Hulin, Cyrille; Grosicki, Sebastian; Legiec, Wojciech; Beksac, Meral; Maiolino, Angelo; Takamatsu, Hiroyuki; Perrot, Aurore; Turgut, Mehmet; Ahmadi, Tahamtan; Liu, Weiping; Wang, Jianping; Chastain, Katherine; Vermeulen, Jessica; Krevvata, Maria; Lopez-Masi, Lorena; Carey, Jodi; Rowe, Melissa; Carson, Robin; Zweegman, Sonja

μMap-FFPE: A High-Resolution Protein Proximity Labeling Platform for Formalin-Fixed Paraffin-Embedded Tissue Samples

μMap-FFPE:一种用于福尔马林固定石蜡包埋组织样本的高分辨率蛋白质邻近标记平台

Bissonnette, Noah B; Zamanis, Marie E; Knutson, Steve D; Boyer, Zane; Harris, Angelo; Martin, Daniel; Geri, Jacob B; Couto, Suzana; Ahmadi, Tahamtan; Muthuswamy, Anantharaman; Fereshteh, Mark; MacMillan, David W C

Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects

Acasunlimab 是一种 Fc 惰性 PD-L1×4-1BB 双特异性抗体,与 PD-1 阻断剂联合使用可通过互补的免疫调节作用增强抗肿瘤免疫力。

Michela Capello # ,Angelica Sette # ,Theo Plantinga ,Craig J Thalhauser ,Vanessa M Spires ,Kristina B Nürmberger ,Jordan M Blum ,Brandon W Higgs ,Patricia Garrido Castro ,Christina Yu ,Carol Costa Sa ,Sina Fellermeier-Kopf ,Saskia M Burm ,Kristin Strumane ,Aras Toker ,Andrea Imle ,Bruna de Andrade Pereira ,Alexander Muik ,Tahamtan Ahmadi ,Özlem Türeci ,Mark Fereshteh ,Ugur Sahin ,Maria Jure-Kunkel ,Nora Pencheva

Dose Selection for DuoBody®-CD40x4-1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data

利用临床前和临床数据,采用 mPBPK/RO 模型选择 DuoBody®-CD40x4-1BB (GEN1042/BNT312) 的剂量

Bajaj, Gaurav; Shchelokov, Dmitry; Demin, Oleg Jr; Adams, Homer C 3rd; Feng, Yan; Gibiansky, Leonid; van der Lee, Saskia; Johri, Anandhi; Belete, Merzu; Muik, Alexander; Panorchan, Porntula; Türeci, Özlem; Sahin, Uğur; Ahmadi, Tahamtan; Gupta, Manish; Demin, Oleg; Thalhauser, Craig

Optimal Dosing Regimen for Epcoritamab, a Subcutaneous Bispecific Antibody, in Relapsed or Refractory Large B-Cell Lymphoma

复发或难治性大B细胞淋巴瘤患者皮下注射双特异性抗体Epcoritamab的最佳给药方案

Li, Tommy; Gibiansky, Leonid; Parikh, Apurvasena; Putnins, Matthew; Chiu, Christopher W; Sacchi, Mariana; Feng, Huaibao; Ahmadi, Tahamtan; Gupta, Manish; Xu, Steven

Upregulation of miR-361-5p attenuates MPP(+)-induced neurotoxicity in dopaminergic SH-SY5Y cells as Parkinson's disease model

miR-361-5p 的上调可减弱 MPP(+) 诱导的多巴胺能 SH-SY5Y 细胞(帕金森病模型)的神经毒性

Vaheb Hosseinabadi, Shiva; Tahamtan, Hananeh; Mahmoudian Esfahani, Maryam; Ghaedi-Heidari, Rasoul; Hashemi, Motahare-Sadat; Peymani, Maryam; Sisakhtnezhad, Sajjad; Fahimi, Hossein; Ghaedi, Kamran

A hexamerization-enhanced, Fc-silenced agonistic CD27 antibody amplifies T-cell effector functions as single agent and in combination with PD-1 blockade

一种经六聚化增强、Fc沉默的激动性CD27抗体,可作为单药或与PD-1阻断剂联合使用,增强T细胞效应功能。

Işıl Altıntaş ,Kristina B Nürmberger ,Andrea Imle ,Anna-Lena Krause ,Marike M van Beuge ,Aras Toker ,Andreea Ioan-Facsinay ,Jordan Blum ,Alexander Muik ,Frank J Beurskens ,Rob N de Jong ,David P E Satijn ,Friederike Gieseke ,Bart-Jan de Kreuk ,Maarten van der Kroef ,Sina Fellermeier-Kopf ,Tahamtan Ahmadi ,Özlem Türeci ,Esther C W Breij ,Uğur Şahin